Authors
Loading...
Prospective cohort study demonstrates reduced inflammation in prevalent hemodialysis patients after high-efficiency HDx, suggesting immune benefits.
Thammathiwat et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: